hepatic echinococcosis
Conditions
Interventions
experimental group:Open transversus abdominis plane block
Control:20ml 0.2% ropivacaine incision subcutaneous injection
Sponsors
Sichuan Academy of Medical Sciences & Sichuan Provincial People's Hospital
Eligibility
Sex/Gender
All
Age
18 Years to 70 Years
Inclusion criteria
Inclusion criteria: Tibetan; Aged<70 years old; Body Mass Index (BMI)<30 kg/m2; American society of Anesthesiologists (ASA) physical status I II; Primary hepatic hydatid
Exclusion criteria
Exclusion criteria: (1) allergy to anesthetics; (2) history of chronic pain; (3) coagulation abnormalities; (4) Liver and/or kidney dysfunction; (5) significant systemic disease.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| PCA sufentanil intake; | — |
Secondary
| Measure | Time frame |
|---|---|
| Time to first flatus; | — |
Countries
China
Contacts
Public ContactYang Mengchang
Sichuan Academy of Medical Sciences & Sichuan Provincial People's Hospital
Outcome results
None listed